Zynerba Pharmaceuticals Inc buy melinda
Start price
11.12.17
/
50%
€11.45
Target price
29.12.17
€15.00
Performance (%)
14.06%
End price
29.12.17
€13.06
Summary
This prediction ended on 29.12.17 with a price of €13.06. The BUY prediction by melinda finished with a performance of 14.06%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Zynerba Pharmaceuticals Inc | - | - | - | - |
iShares Core DAX® | 1.776% | 3.175% | 14.882% | 17.660% |
iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% | 52.324% |
iShares Nikkei 225® | -0.335% | 3.857% | 14.485% | 11.459% |
iShares S&P 500 | 0.854% | 2.567% | 31.105% | 47.441% |
According to melinda what are the pros and cons of Zynerba Pharmaceuticals Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Zynerba Pharmaceuticals Inc diskutieren
Bietet dermale Lösungen für die Behandlung von neurologischen Erkrankungen
Zynerba Pharmaceuticals, Inc. engagiert in der Forschung und Entwicklung von Arzneimitteln.
Klinische Programme umfassen synthetische Cannabinoid - Therapien und Patches und Gele für die transdermale Verabreichung.
Das Unternehmen wurde von Audra L. Stinchcomb 31. Januar 2007 gegründet und hat ihren Sitz in Devon, PA.
Zynerba Pharmaceuticals, Inc. engagiert in der Forschung und Entwicklung von Arzneimitteln.
Klinische Programme umfassen synthetische Cannabinoid - Therapien und Patches und Gele für die transdermale Verabreichung.
Das Unternehmen wurde von Audra L. Stinchcomb 31. Januar 2007 gegründet und hat ihren Sitz in Devon, PA.
Anzahl der Mitarbeiter: 12 Personen.
(Vom Mitglied beendet)
Stopped prediction by melinda for Zynerba Pharmaceuticals Inc
Zynerba Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.28
17.09.23
17.09.23
-
17.09.24
17.09.24
-4.69%
10.12.23
10.12.23
Could be worthwhile Investment >10% per year
Zynerba Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.50
08.03.21
08.03.21
€5.00
08.03.22
08.03.22
-49.79%
09.03.22
09.03.22
Could be worthwhile Investment >10% per year
Zynerba Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€7.34
10.02.21
10.02.21
€5.50
-52.34%
08.03.21
08.03.21
Could be worthwhile Investment >10% per year
Zynerba Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.71
03.04.19
03.04.19
€10.82
11.06.19
11.06.19
115.78%
11.06.19
11.06.19
Could be worthwhile Investment >10% per year
Zynerba Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€10.69
13.01.18
13.01.18
€12.13
13.07.18
13.07.18
-13.80%
13.07.18
13.07.18
Could be worthwhile Investment >10% per year
Zynerba Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€10.33
11.12.17
11.12.17
€13.53
29.12.17
29.12.17
14.06%
29.12.17
29.12.17
Could be worthwhile Investment >10% per year
Zynerba Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€6.22
15.08.17
15.08.17
€16.50
20.10.17
20.10.17
55.14%
20.10.17
20.10.17
Could be worthwhile Investment >10% per year
Zynerba Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.61
15.08.17
15.08.17
€14.88
20.10.17
20.10.17
55.14%
20.10.17
20.10.17
Could be worthwhile Investment >10% per year
Zynerba Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€20.25
27.02.17
27.02.17
€21.65
10.04.17
10.04.17
7.35%
10.04.17
10.04.17
Could be worthwhile Investment >10% per year